All individuals should also undergo screening for hepatitis A immunity (hepatitis A IgG) and for hepatitis B (HBsAg, anti-HBs, and anti-HBc) and should be vaccinated if nonimmune. This evidence concerns the gene KRT88P and hepatitis B virus infection.